孕期糖尿病母亲产后对胰岛素抵抗指标的评估:一项前性观察病例控制研究
Karolina Karcz1, Paulina Gaweł1, Barbara Królak-Olejnik1
1Department of Neonatology, Wroclaw Medical University, Poland.
概括
产后胰岛素耐药性 (IR) 标志物如HOMA-IR和HbA1c在孕期糖尿病 (GDM) 的母亲中较高. 识别高风险的GDM表型有助于针对性护理,以改善妊娠结果.
科学领域:
- 生殖内分泌学 生殖内分泌学
- 代谢障碍 代谢障碍 代谢障碍
- 孕产妇与胎儿的医学
背景情况:
- 妊娠期糖尿病 (GDM) 与正常怀孕相比,呈现出胰岛素抵抗 (IR) 的增加.
- 胰岛素敏感性的替代标志物包括糖化血红蛋白 (HbA1c),HOMA-IR和QUICKI.
- 评估产后IR对于了解患有GDM的母亲的长期代谢健康至关重要.
研究的目的:
- 为了比较GDM和非GDM母亲之间的产后IR标志物.
- 根据GDM治疗 (饮食/运动与胰岛素) 来评估IR标志物的差异.
- 调查红外线标记物,妊娠结果和口服葡萄糖耐受性测试 (OGTT) 档案之间的关联.
主要方法:
- 研究包括70名参与者:50名GDM患者 (21名饮食/运动,29名胰岛素) 和20名对照患者.
- 统计分析包括ANOVA,克鲁斯卡尔-瓦利斯,奇平方,回归和集群分析 (α = 0.05).
- 红外线标志物 (HOMA-IR,HbA1c,QUICKI) 和OGTT葡萄糖水平在产后第一周被评估.
主要成果:
- 与对照组相比,患有GDM的母亲的产后HOMA-IR和HbA1c水平显著更高.
- 在GDM和对照组之间没有观察到QUICKI的显著差异.
- 在多个时间点中,GDM母亲的OGTT葡萄糖水平升高;胰岛素治疗的GDM患者通常比饮食治疗的患者具有更高的IR标志物.
- 集群分析揭示了不同的母体葡萄糖表型,表明不同的葡萄糖代谢障碍.
结论:
- 产后IR标志物在GDM和非GDM母亲之间有显著差异.
- 通过集群分析识别的GDM表型可以帮助分层风险.
- 针对高风险GDM群体的有针对性的咨询和监测可以改善妊娠结果.
相关概念视频
Pathophysiology of Diabetes
4.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.2K
Diabetes Mellitus: Type 2 and Gestational
5.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K
Diabetes: Symptoms, Diagnosis, and Complications
2.7K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.7K
Diabetes Mellitus: Overview and Type I Subtype
5.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.8K
Oral Hypoglycemic Agents: Biguanides and Glitazones
830
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
830
Insulin: Dosing Regimen and Adverse Effects
1.1K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.1K


